This story was first published in digitalhealth.net
Life-extending injection for blood cancer available on NHS
A life-extending injection for a fatal form of blood cancer will be available to around 350 patients per year in England.
NHS England chief executive Amanda Pritchard announced that the drug, which can extend the lives of patients with a recurring and incurable cancer of the bone marrow cells – known as multiple myeloma – by an average of nine months, has been given the green light for routine use by NICE after it was made available for a limited period through the Cancer Drugs Fund.
Myeloma cannot be cured and treatment is usually about keeping the cancer at bay for as long as possible with the least side-effects from treatment.
The new treatment, a drug called daratumumab, will be offered to patients with recurring multiple myeloma who have tried at least three other treatments will help multiple myeloma patients live longer lives whilst improving their quality of life. It also gives patients a greater chance of accessing further treatments that may help them live even longer, healthier lives.
Pritchard said: “This quick injection can have a real impact on the lives of patients and their families and so it is important news that it is now routinely available on the NHS. The drug will offer a ray of light to hundreds of people each year who have had limited success with other treatments for this devastating, advanced blood cancer.
“It is also the latest in a long list of cutting-edge, targeted cancer treatments that the NHS has secured routine access to through the Cancer Drugs Fund, making it good value for taxpayers too. The NHS has continued to prioritise cancer care throughout the pandemic and I urge anyone with concerns, to come forward and get checked.”
The NHS Long Term Plan is committed to providing the latest cutting-edge treatments and therapies for patients, and the Cancer Drugs Fund provides faster access to promising cancer treatments on the health service in England.
Latest News
16/02/2024 - 12:56
Hammersmith and Fulham Council has created a new alliance intended to clean dirty air and improve residents' health.
16/02/2024 - 10:44
Two million more GP appointments a month are being delivered for patients compared to the same month before the pandemic as part of the NHS primary care access recovery plan according to new NHS data.
15/02/2024 - 10:26
The Welsh Government has provided innovation funding of £380,000 to support two projects utilising technology in domiciliary care.
15/02/2024 - 10:13
The new Scottish health secretary has met with frontline staff at Queen Elizabeth University Hospital in Glasgow.
14/02/2024 - 10:27
The North East London NHS Foundation Trust (NELFT) has appointed three new Executive Directors to the Trust Board.
Product Features
UK Building Regulations highlight toxic gas and smoke from layers of paint built up over multiple redecorations as a major cause of permanent ill health or death in a building fire.
Their concern rose with discovery the flame retardant paints most widely used paint along escape routes have been ones which to this day counter-productively use emission of heavy toxic gas to smother flames which rapidly spread along walls if layers of paint delaminate in a fire.
Supplier Profiles
Northwich’s Victoria Infirmary (VIN) Community Diagnostic Centre (CDC) has enabled more patients
Adveco, the commercial hot water specialist, announces the launch of live metering of domestic ho
Latest Features
Sarah Greenslade, public affairs and communications officer at the British Parking Association looks at some of the problems and innovations in healthcare parking
It’s easy to assume that the comms team is there to handle press enquiries and the occasional social media storm – but the reality is that strategic communications can make a measurable impact across the entire organisation, from operational to financial, when done properly
